Editorial Staff
NewsWriter.ai
@editorial-staff
Newswriter.ai is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
23607 articles
Articles

Forward Industries Reports Over 6.97 Million SOL Holdings with 6.73% Gross APY
Forward Industries (NASDAQ: FWDI) has provided an update on its Solana treasury holdings, revealing the company now holds over 6.97 million SOL tokens. The company's validator infrastructure has generated 6.73% gross annual percentage yield before fees, outperforming many top peer validators in the ecosystem.The update deta...
January 29, 2026Read the full article

Numa Numa Resources Advances Panguna Mine Development Amid Global Copper Supply Crunch
The global energy transition is quietly elevating copper to a position of strategic importance, creating a supply-demand imbalance that companies like Numa Numa Resources Inc. are positioned to address. Numa Numa is advancing development efforts on the Panguna Mine project on Bougainville Island in the South Pacific, a site...
January 29, 2026Read the full article

Forward Industries Launches First Regulated Public Equity as DeFi Collateral on Solana
Forward Industries Inc. (NASDAQ: FWDI) has announced that its SEC-registered shares are now live on the Solana blockchain through Superstate's Opening Bell platform, creating the first instance where regulated public equity can be used as collateral within a live decentralized finance (DeFi) market. This development represe...
January 29, 2026Read the full article

Soligenix Advances Novel Photodynamic Therapy for Early-Stage Cutaneous T-Cell Lymphoma
Soligenix Inc. (NASDAQ: SNGX) is advancing a novel therapeutic approach for cutaneous T-cell lymphoma through its development of HyBryte™, also known as synthetic hypericin. CTCL is recognized by clinicians as one of the most difficult cancers to diagnose accurately in its early stages, creating a challenging diagnostic and...
January 29, 2026Read the full article

National Eye Institute Highlights Low Vision Awareness and Rehabilitation Resources
Millions of Americans live with low vision, a visual impairment that complicates daily activities such as reading, driving, and recognizing faces. While the conditions causing low vision become more common with age, it is not a natural part of aging. Common causes include age-related macular degeneration, cataracts, glaucom...
January 29, 2026Read the full article

Soligenix Advances HyBryte Therapy for Early-Stage Cutaneous T-Cell Lymphoma Treatment
Soligenix Inc. is advancing HyBryte, a novel photodynamic therapy for early-stage cutaneous T-cell lymphoma that addresses significant challenges in both diagnosis and treatment of this rare cancer. Cutaneous T-cell lymphoma presents particular difficulties for clinicians attempting accurate early-stage diagnosis, creating ...
January 29, 2026Read the full article

Soligenix Advances Targeted CTCL Therapy HyBryte™ to Address Critical Treatment Gaps
Soligenix Inc. (NASDAQ: SNGX) is advancing a novel therapeutic approach for cutaneous T-cell lymphoma through its development of HyBryte™, also known as synthetic hypericin. CTCL is recognized by clinicians as one of the most difficult cancers to diagnose accurately in its early stages, creating significant challenges withi...
January 29, 2026Read the full article

Soligenix Advances Novel Photodynamic Therapy HyBryte for Early-Stage Cutaneous T-Cell Lymphoma
Soligenix Inc. is advancing a novel therapeutic approach for cutaneous T-cell lymphoma through its development of HyBryte, also known as synthetic hypericin. CTCL is recognized by clinicians as one of the most difficult cancers to diagnose accurately in its early stages, creating a challenging diagnostic and treatment lands...
January 29, 2026Read the full article

Soligenix Advances Novel HyBryte Therapy for Early-Stage Cutaneous T-Cell Lymphoma
Soligenix Inc. is advancing a novel therapeutic approach for cutaneous T-cell lymphoma through its development of HyBryte, also known as synthetic hypericin. CTCL is recognized by clinicians as one of the most difficult cancers to diagnose accurately in its early stages, creating a challenging diagnostic and treatment lands...
January 29, 2026Read the full article

Trilogy Metals Strengthens Leadership and Announces 2026 Budget Following Federal Investment in Alaska Critical Minerals Project
Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) is expanding its advisory and leadership teams and has released its corporate budget for 2026 following a recent federal investment aimed at advancing the Upper Kobuk Mineral Projects in northwestern Alaska. The company, a mine development and exploration firm, received th...
January 29, 2026Read the full article

Powermax Minerals Completes 2025 Field Exploration Program at Atikokan REE Property
Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) has completed its 2025 field exploration program at the Atikokan Rare Earth Elements property, marking a significant technical milestone for the Canadian mineral exploration company. The property is located in the Atikokan–Ignace–White Otter Lake district of northwestern Ont...
January 29, 2026Read the full article

GlobalTech Acquires Controlling Stake in U.K. Footwear Brand Moda in Pelle to Deploy AI Platform
GlobalTech Corporation (OTC: GLTK) has completed the acquisition of a 51% controlling stake in 123 Investments Limited, which operates as the premium U.K. footwear brand Moda in Pelle. The transaction is designed to provide GlobalTech with an additional revenue stream while expanding the company's ecommerce and direct-to-co...
January 29, 2026Read the full article

BioVaxys Phase 2 Data Shows Promise for Maveropepimut-S in Metastatic Bladder Cancer
BioVaxys Technology Corp. announced positive findings from a Phase 2 clinical study evaluating maveropepimut-S (MVP-S) in combination with pembrolizumab and low-dose cyclophosphamide in patients with advanced or metastatic bladder cancer. The results build on the company's recent Phase 1B/2 data in advanced ovarian cancer a...
January 29, 2026Read the full article

SEGG Media Corp. Secures Dismissal of Remaining Legacy Litigation Claims in Federal Court
The United States District Court for the Middle District of Florida has dismissed all remaining claims in a legacy litigation matter against SEGG Media Corp., marking a procedural conclusion to a case that had been pending against the company. The dismissal, which occurred without prejudice, followed a January 28, 2026, cou...
January 29, 2026Read the full article

Search Minerals Emphasizes Leadership Experience in Critical Rare Earth Development Strategy
Search Minerals Inc. (TSX.V: SMY) (OTC: SHCMF) has positioned its leadership team's extensive experience as a central driver in advancing its critical minerals development strategy. The company's growth approach recognizes that successful critical minerals development depends not only on geology and technology but also on l...
January 29, 2026Read the full article

Lynnwood Orthodontics Expands Access to Advanced Dental Technology and Personalized Care
Lynnwood Orthodontics has announced its commitment to providing expert orthodontic care to the local community with specialized treatment plans for children, teens, and adults. The practice focuses on creating healthy, confident smiles through tailored approaches that address individual patient needs. For community members ...
January 29, 2026Read the full article

LaFleur Minerals Advances Mill Recommissioning Amid Record Gold Prices
LaFleur Minerals Inc. has made significant progress in recommissioning its 100%-owned Beacon Gold Mill located in Val d'Or, Quebec, within the prolific Abitibi gold belt. The company has completed electrical and heating upgrades, cleanup measures, and mechanical inspections at the facility, which is strategically positioned...
January 29, 2026Read the full article

Rail Vision Acquires Quantum Transportation Stake to Enhance AI Rail Safety Technology
Rail Vision Ltd. (NASDAQ: RVSN) has completed its acquisition of a 51% ownership interest in Quantum Transportation, a strategic move that adds quantum error correction technologies to the company's portfolio of rail safety solutions. The transaction positions Rail Vision to leverage Quantum Transportation's expertise in ar...
January 29, 2026Read the full article

Earth Science Tech's 47% Insider Ownership Signals Strong Management Alignment with Investors
Earth Science Tech Inc. (OTC: ETST) demonstrates a notable departure from typical over-the-counter market patterns through its management team's substantial ownership of 47% of company shares. This high level of insider ownership represents a significant alignment of interests between company leadership and outside investor...
January 29, 2026Read the full article

McEwen Inc. Announces Acquisition of Golden Lake Exploration to Expand Nevada Gold Bar Mine Complex
McEwen Inc. (NYSE: MUX) (TSX: MUX) announced on Wednesday that it has entered into a definitive agreement to acquire all issued and outstanding shares of Golden Lake Exploration Inc. (CSE: GLM) by way of a court-approved plan of arrangement. Under this agreement, Golden Lake would become a wholly owned subsidiary of McEwen....
January 29, 2026Read the full article

Provident Financial Services Reports Record Revenue and Profit Growth in Q4 2025
Provident Financial Services Inc (NYSE: PFS) delivered another strong quarter of expanding profitability and continued operating momentum according to coverage updates from Stonegate Capital Partners. Net income increased to $83.4 million, resulting in earnings per share of $0.64 and driving a return on average assets of 1....
January 29, 2026Read the full article

